Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Formaldehyde Substitute Fixatives Appraised for Histology

By LabMedica International staff writers
Posted on 28 Sep 2011
In histology and pathology laboratories, neutral buffered formalin (NBF) has been the gold standard fixative for decades, but formaldehyde is known to be toxic. More...


Other less toxic alcohol-based cross-linking or non–cross-linking fixatives have advantages that include faster fixation; elimination of carcinogenic vapors; better preservation of glycogen, DNA, and RNA; greater staining avidity; and no need for enzyme predigestion for immunohistochemical analysis.

Scientists at the University Medical Center Utrecht (the Netherlands) tested three cross-linking and non–cross-linking alcohol-based fixatives for routine staining in comparison with NBF, an aqueous solution of 4% buffered formaldehyde. The aim was to observe the fixation on tissue morphologic features and the quality of special histological stains and immunohistochemical stains in comparison with NBF.

Fresh tissue samples from many different organs were divided into four equal pieces and fixed in all fixatives for varying times. After paraffin embedding, staining with hematoxylin and eosin (H&E), seven common histochemical stains, and nine common immunohistochemical stains were performed. Fixation with the non-linking RCL2 (Alphelys; Plaisir, France) resulted in soft and slippery tissue, causing sectioning difficulties. The cross-linking the aldehyde-containing F-Solv (Adamas; Rhenen, The Netherlands) and the non–cross-linking FineFIX (Milestone; Bergamo, Italy) led to partial tissue disintegration during fixation.

F-Solv performed morphologically similar to NBF but needed considerable protocol adjustments before being applicable in daily histology and immunohistochemical practice. FineFIX did not necessitate major protocol changes but caused shrinkage artifacts, degranulation, and lysis of red blood cells (RBC). RCL2 generated morphologically overall good results without major protocol changes, but caused pigment deposition, degranulation, and erythrocytic lysis. The alcohol-based fixatives had positive and negative attributes and environmental drawbacks, and none was overall comparable to NBF with regard to macroscopy, morphologic evaluation, and immunohistochemical studies.

The authors concluded that before replacing formalin with another fixative in a surgical pathology laboratory, all levels of pathology must be examined thoroughly. At the histochemical and the immunohistochemical levels using the usual NBF-based protocols, NBF performance was superior, followed by FineFIX/RCL2 and F-Solv. The study was published online in for the October 2011 edition of the Journal of Clinical Pathology.

Related Links:

University Medical Center Utrecht
Alphelys
Adamas




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.